| Hepatocellular carcinoma (HCC) | transforming growth factor-β (TGF-β) |
| nonalcoholic fatty liver disease (NAFLD) | reactive oxygen species (ROS) |
| hepatitis B virus (HBV) | Receptor for activated C kinase1 (RACK1) |
| hepatitis C virus (HCV) | Myeloid cell leukemia-1 (Mcl-1) |
| HBV X protein (HBx) | Transforming acidic coiled-coil protein 3 (TACC3) |
| Aflatoxin B1 (AFB1) | GATA transcription factor 5 (GATA5) |
| tumor necrosis factor-α (TNF-α) | Level of Atonal homolog 8 (ATOH8) |
| interleukin 6 (IL-6) | basic-helix-loop-helix (bHLH) |
| programmed death-ligand 1 (PD-L1) | Zinc finger E-box binding Hox 1 (ZEB1) |
| programmed cell death 1 (PD-1) | MYC-associated zinc finger protein (MAZ) |
| tumor-initiating stem-like cells (TICs) | microRNAs (miRNAs) |
| mesenchymal transition (EMT) | long non-coding RNAs (lncRNAs) |
| epithelial cell adhesion molecule (EpCAM) | Long non-coding RNA activated by TGF-β (lncRNA-ATB) |
| octamer-binding transcription factor 4 (Oct4) | intestine-specific homeobox transcription factor (ISX) |
| insulin-like growth factor (IGF) 2 | aryl hydrocarbon receptor (AhR) |
| IGF 1 receptor (IGF1R) | Toll-like receptor 4 (TLR4) |
| vascular endothelial growth factor (VEGF) | Damage-associated molecular patterns (DAMPs) |